Scott Reents
Director of Finance/CFO bei TOBIRA THERAPEUTICS INC
Vermögen: 3 Mio $ am 31.03.2024
Profil
Scott T.
Reents is currently the President & Director at Allergan, Inc. and Oculeve, Inc. He is also the Chief Financial Officer & Executive Vice President at AbbVie, Inc. and the Chief Financial Officer at Tobira Therapeutics, Inc. Previously, he worked as the Vice President-Tax at Abbott Laboratories.
Mr. Reents completed his undergraduate degree at the University of Nebraska and holds graduate and MBA degrees from the University of Washington.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ABBVIE, INC.
0,00% | 28.02.2024 | 15 431 ( 0,00% ) | 3 Mio $ | 31.03.2024 |
Aktive Positionen von Scott Reents
| Unternehmen | Position | Beginn |
|---|---|---|
| TOBIRA THERAPEUTICS INC | Director of Finance/CFO | - |
| ABBVIE INC. | Director of Finance/CFO | 23.06.2022 |
| ALLERGAN, INC. | President | - |
Oculeve, Inc.
 Oculeve, Inc. Medical SpecialtiesHealth Technology Oculeve, Inc. develops devices for dry eye disease treatment. The company was founded by D. Michael Ackermann, Brandon M. Felkins, Garrett Cale Smith and Victor Wayne McCray in 2011 and is headquartered in Parsippany, NJ. | President | - |
Ehemalige bekannte Positionen von Scott Reents
| Unternehmen | Position | Ende |
|---|---|---|
| ABBOTT LABORATORIES | Comptroller/Controller/Auditor | - |
Ausbildung von Scott Reents
| University of Nebraska | Undergraduate Degree |
| University of Washington | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| ABBVIE INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Oculeve, Inc.
Oculeve, Inc. Medical SpecialtiesHealth Technology Oculeve, Inc. develops devices for dry eye disease treatment. The company was founded by D. Michael Ackermann, Brandon M. Felkins, Garrett Cale Smith and Victor Wayne McCray in 2011 and is headquartered in Parsippany, NJ. | Health Technology |
Tobira Therapeutics, Inc.
 Tobira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The company was founded on October 6, 2006 and is headquartered in Madison, NJ. | Health Technology |
